Eupafolin nanoparticle improves acute renal injury induced by LPS through inhibiting ROS and inflammation
Authors:
- 1 January 2017
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 85, 704-711
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Acute Kidney InjuryAnnual Review of Medicine, 2016
- A polycystin-centric view of cyst formation and disease: the polycystins revisitedKidney International, 2015
- Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular diseaseExpert Opinion on Investigational Drugs, 2014
- Nanoparticle-Delivered Quercetin for Cancer TherapyAnti-Cancer Agents in Medicinal Chemistry, 2014
- Structure-Activity Association of Flavonoids in Lung DiseasesMolecules, 2014
- Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapyPediatric Research, 2013
- Combined biomarkers evaluation for diagnosing kidney injury in preeclampsiaHypertension in Pregnancy, 2013
- Recent Advances in Biologically Active Compounds in Herbs and Spices: A Review of the Most Effective Antioxidant and Anti-Inflammatory Active PrinciplesCritical Reviews in Food Science and Nutrition, 2013
- Eupatorium perfoliatum L.: Phytochemistry, traditional use and current applicationsJournal of Ethnopharmacology, 2011
- Antioxidant Activity of Chemical Components from Sage (Salvia officinalis L.) and Thyme (Thymus vulgaris L.) Measured by the Oil Stability Index MethodJournal of Agricultural and Food Chemistry, 2002